Product Overview

Leukapheresed Naïve CD4+ T cells are negatively selected using a two step isolation process. CD4+ T Cells are first negatively selected from mononucleated cells using an indirect immunomagnetic CD4+ labeling system. CD45RO microbeads are then used to deplete the CD45RO+ population, leaving a highly enriched CD4+ CD45RA+ Naïve T Cell population. Cells are cryopreserved in Lonza Cryo Media in a cryovial. Cell purity is determined post thaw using a FACS assay. Count and viability is determined using AO/PI. Cells are collected from healthy donors following IRB protocols. Manufactured by AllCells®

Content

1 vial containing ≥ 5 million cryopreserved cells

Recommended Media

Lonza X-VIVO™ 20 with L-glutamine, gentamicin and phenol red

Lonza X-VIVO™ 20 Serum-free Hematopoietic Cell Medium

Catalog #: 4W-202

Please email us at cs@medikonia.com for any enquiry. To place an order, please include the catalog number(s) of the product(s) in the email.

Procedure for thawing Poietics™ cells

Reference guidefor human and animal cells from normal to diseased, fresh and cryopreserved